Arrhythmia Alliance News & Events
Don't let cancelled/postponed conferences stop your educational learning! We have a large number of educational presentations available online HERE
News - Londoners advised 'know your pulse' during Heart Rhythm Week
Londoners are being invited to take a free, 30 second pulse check during Heart Rhythm Week. This simple check could prolong or even save their life. Heart rhythm disorders (arrhythmia) happen when a heart rhythm is too fast, too slow, or jumping around (irregular).
New patient survey results show 80% of AF patients say ‘YES’ to the freedom that INR self-monitoring gives them
The purpose of this survey was to help discover patient thoughts and opinions about INR self-monitoring versus clinic visits. Several trials have demonstrated that patient self-monitoring (PSM) by those on long term warfarin significantly improves time in therapeutic range (TTR) and leads to better management outcomes.
Arrhythmia Alliance Launches APPG-A
Arrhythmias are a critical health concern in the UK, but the necessary policy attention and resource focus is limited. There are many issues from a management and service provision perspective that need to be addressed for the benefit of patients and the NHS. A strong political voice is necessary to help raise these issues and help to effect positive change.
Combination of principal component analysis and optical-flow motion compensation for improved cardiac MR thermometry
The use of magnetic resonance (MR) thermometry for the monitoring of thermal ablation is rapidly expanding. However, this technique remains challenging for the monitoring of the treatment of cardiac arrhythmia by radiofrequency ablation due to the heart displacement with respiration and contraction. Recent studies have addressed this problem by compensating in-plane motion in real-time with optical-flow based tracking technique.
Pharmacists Demand Radical Reform of Care For People With Long Term Conditions
Community pharmacists must be able to routinely prescribe medicines for people with long term conditions and refer them directly to other healthcare professionals to ease the overwhelming demand facing the NHS says the Royal Pharmaceutical Society (RPS) in a new report to be launched at the House of Commons on 30th November.
New medical grade single lead ECG on your WRIST helps discover possible Atrial Fibrillation, a leading cause of stroke in the UK
58 Year Old Saved By Bluffton Police Department Using AED donated by Arrhythmia Alliance Defibs Saves Lives – Gavin Quance Campaign
October 26th , 2016, Hilton Head Island, South Carolina: Arrhythmia Alliance, a leading international heart rhythm charity based in South Carolina, is pleased to announce that a 58-year old male was saved yesterday by the Bluffton Police Department by one of the defibrillators that was recently placed in the vehicles from the Arrhythmia Alliance – Defibs Save Lives – Gavin Quance Campaign. Officers responded to a report of a 58 year old male who had collapsed. Upon arrival, ahead of paramedics, the officers perfomed CPR and used the AED from the vehicle. After two shocks, they brought the person back. He was breathing and is currently being treated at Hilton Head Hospital.
Arrhythmia Alliance Medical Director Named President Elect of British Heart Rhythm Society
Friday 21 October, Birmingham, UK: Arrhythmia Alliance is pleased to announce that its Medical Director, Professor Richard Schilling, St Bartholomew’s Hospital, London has been chosen as the next President of the British Heart Rhythm Society – the world’s first heart rhythm society established in 1976. This further reinforces the strong links between the UK’s leading Heart Rhythm Charity and the Cardiac Specialists professional organization, combining the voice of the patient with that of the physician.
Arrhythmia Alliance places 3000th Public Access Defibrillator on World Restart the Heart Day
“AEDs must be as commonplace as fire extinguishers and smoke alarms if we are to dramatically reduce the number of deaths from sudden cardiac arrest in the UK.”
New real-world analysis reports lower risk of major bleeding with dabigatran compared to rivaroxaban in stroke prevention
Ingelheim, Germany, 13.October 2016 – A large observational study by researchers from the U.S. FDA has found that dabigatran (150 mg twice daily) was associated with lower rates of intracranial haemorrhage and major extracranial bleeding, including major gastrointestinal bleeding than rivaroxaban (20 mg once daily) in patients with atrial fibrillation (AF). The study is the largest observational study to-date comparing the two drugs, and analysed data from over 118,000 AF patients. Based on the data published in JAMA Internal Medicine, the accompanying Editor’s Note written by Parks and Redberg suggests that physicians should “prescribe dabigatran over rivaroxaban for patients with atrial fibrillation.”